Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference Lead Investing
Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes Lead Investing
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress Lead Investing
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights Lead Investing
